BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $12.96 million. The enterprise value is $7.51 million.

Market Cap	12.96M
Enterprise Value	7.51M

Important Dates

The last earnings date was Wednesday, March 12, 2025, after market close.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BCTX has 3.71 million shares outstanding. The number of shares has increased by 58.67% in one year.

Current Share Class	3.71M
Shares Outstanding	3.71M
Shares Change (YoY)	+58.67%
Shares Change (QoQ)	+52.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.02
P/TBV Ratio	3.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.37

Current Ratio	1.37
Quick Ratio	1.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-158.14%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-661.06%
Revenue Per Employee	n/a
Profits Per Employee	-$724,500
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.77% in the last 52 weeks. The beta is 1.86, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.86
52-Week Price Change	-91.77%
50-Day Moving Average	4.32
200-Day Moving Average	9.89
Relative Strength Index (RSI)	39.03
Average Volume (20 Days)	45,599

Short Selling Information

The latest short interest is 188,090, so 5.07% of the outstanding shares have been sold short.

Short Interest	188,090
Short Previous Month	184,076
Short % of Shares Out	5.07%
Short % of Float	5.88%
Short Ratio (days to cover)	1.48

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.32M
Pretax Income	-6.04M
Net Income	-11.59M
EBITDA	-27.19M
EBIT	-27.32M
Earnings Per Share (EPS)	-$6.92

Full Income Statement

Balance Sheet

The company has $5.01 million in cash and n/a in debt, giving a net cash position of $5.01 million or $1.35 per share.

Cash & Cash Equivalents	5.01M
Total Debt	n/a
Net Cash	5.01M
Net Cash Per Share	$1.35
Equity (Book Value)	3.23M
Book Value Per Share	1.22
Working Capital	1.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.99 million and capital expenditures -$456,801, giving a free cash flow of -$22.45 million.

Operating Cash Flow	-21.99M
Capital Expenditures	-456,801
Free Cash Flow	-22.45M
FCF Per Share	-$6.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.67%
Shareholder Yield	-58.67%
Earnings Yield	-89.45%
FCF Yield	-173.24%

Analyst Forecast

The average price target for BCTX is $32.00, which is 822.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	822.19%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 29, 2025. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Jan 29, 2025
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a